These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3270335)

  • 21. Level of serum gastrin as a predictor of liver metastasis from colorectal cancer.
    Kameyama M; Fukuda I; Imaoka S; Nakamori S; Iwanaga T
    Dis Colon Rectum; 1993 May; 36(5):497-500. PubMed ID: 8482170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis.
    Watson SA; Smith AM
    Cancer Res; 2001 Jan; 61(2):625-31. PubMed ID: 11212260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum gastrin concentrations in colorectal cancer patients.
    Charnley RM; Thomas WM; Stanley J; Morris DL
    Ann R Coll Surg Engl; 1992 Mar; 74(2):138-40; discussion 141. PubMed ID: 1567134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating gastrin and ghrelin levels in patients with colorectal cancer: correlation with tumour stage, Helicobacter pylori infection and BMI.
    D'Onghia V; Leoncini R; Carli R; Santoro A; Giglioni S; Sorbellini F; Marzocca G; Bernini A; Campagna S; Marinello E; Vannoni D
    Biomed Pharmacother; 2007; 61(2-3):137-41. PubMed ID: 17258885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum gastrin levels and colorectal neoplasia.
    Elewaut A; Vanderstraeten E
    Gastroenterology; 1995 Feb; 108(2):618-9. PubMed ID: 7695754
    [No Abstract]   [Full Text] [Related]  

  • 26. Postprandial hypergastrinaemia in patients with colorectal cancer.
    Wong K; Beardshall K; Waters CM; Calam J; Poston GJ
    Gut; 1991 Nov; 32(11):1352-4. PubMed ID: 1752467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastrin and colorectal cancer: a prospective study.
    Thorburn CM; Friedman GD; Dickinson CJ; Vogelman JH; Orentreich N; Parsonnet J
    Gastroenterology; 1998 Aug; 115(2):275-80. PubMed ID: 9679032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastrin levels in colorectal cancer.
    Niv Y; Heizelracht N; Lamprecht SA; Sperber AD; Fraser GM; Schwartz B
    Isr J Med Sci; 1997 Mar; 33(3):186-9. PubMed ID: 9313788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients.
    Kumor A; Daniel P; Pietruczuk M; Małecka-Panas E
    Int J Colorectal Dis; 2009 Mar; 24(3):275-81. PubMed ID: 18979105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased fasting serum levels of growth hormone and gastrin in patients with gastric and large bowel cancer.
    Triantafillidis JK; Merikas E; Govosdis V; Konstandellou E; Cheracakis P; Barbatzas C; Tzourmakliotis D; Peros G
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():cclvi-cclx. PubMed ID: 15244195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The significance of elevated levels of gastrin in patients with pituitary adenoma.
    Fonseca ME; Zarate A
    Clin Endocrinol (Oxf); 1987 Oct; 27(4):403-8. PubMed ID: 3436069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of visceral fat accumulation and adiponectin levels with colorectal neoplasia.
    Erarslan E; Turkay C; Koktener A; Koca C; Uz B; Bavbek N
    Dig Dis Sci; 2009 Apr; 54(4):862-8. PubMed ID: 18716871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastrin and colorectal cancer. Evidence against an association.
    Yapp R; Modlin IM; Kumar RR; Binder HJ; Dubrow R
    Dig Dis Sci; 1992 Apr; 37(4):481-4. PubMed ID: 1551333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CCK-8 and gastrin plasma levels in cholecystectomized and colorectal cancer patients.
    Rogy MA; Kovats E; Koss G; Müller M; Függer R; Steininger R; Pilz E; Rauhs R; Fritsch A
    Int J Colorectal Dis; 1993 Sep; 8(3):154-7. PubMed ID: 8245672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gastrin and colorectal cancer].
    Casella C; Palmieri F; Fontana MG; Ruggeri G; Albertini A; Salerni B
    Ann Ital Chir; 2001; 72(1):67-72. PubMed ID: 11464499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of the minimal essential serum folate concentration for reduced risk of colorectal adenoma.
    Fujimori S; Gudis K; Takahashi Y; Kotoyori M; Tatsuguchi A; Ohaki Y; Sakamoto C
    Clin Nutr; 2011 Oct; 30(5):653-8. PubMed ID: 21612847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum levels of gastrin in patients with colorectal cancer.
    Suzuki H; Matsumoto K; Yamamoto J
    J Clin Gastroenterol; 1992 Sep; 15(2):166-7. PubMed ID: 1401834
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of serum nucleoside diphosphate kinase A for the detection of colorectal cancer.
    Otero-Estévez O; De Chiara L; Barcia-Castro L; Páez de la Cadena M; Rodríguez-Berrocal FJ; Cubiella J; Hernández V; Martínez-Zorzano VS
    Sci Rep; 2016 May; 6():26703. PubMed ID: 27222072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastrin and colon cancer. Clarifying the controversy.
    Begos DG; Modlin IM
    J Clin Gastroenterol; 1994 Apr; 18(3):189-93. PubMed ID: 8034912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical evaluation of the role of gastrinemia and tumor tissue sensitivity to gastrin in cancer of the large intestines].
    Khalturin VIu; Gamaiunova VB; Berstein LM
    Vopr Onkol; 1997; 43(6):575-9. PubMed ID: 9479354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.